Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastomaElizabeth C. Randall, Nathalie Y.R. Agar, Ann C. Mladek et al.|Nature Communications|2018Cited by 79
Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast CancerHui Liu, Lewis C. Cantley, Charles J. Murphy et al.|Cancer Discovery|2017Cited by 76
Characterization of <i>In Vivo</i> Resistance to Osimertinib and JNJ-61186372, an EGFR/Met Bispecific Antibody, Reveals Unique and Consensus Mechanisms of ResistanceKristina B. Emdal, Forest M. White, Antje Dittmann et al.|Molecular Cancer Therapeutics|2017Cited by 31
Characterization of in vivo resistance to osimertinib and JNJ-61186372, an EGFR/Met bi-specific antibody, reveals unique and consensus mechanisms of resistanceKristina B. Emdal, Forest M. White, Antje Dittmann et al.|PMC|2017Cited by 3